• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    DexCom, Inc. - Common Stock (NQ:DXCM)

    72.29 +1.06 (+1.49%)
    Streaming Delayed Price Updated: 12:16 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about DexCom, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    49 50 Next >
    News headline image
    3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound ↗
    Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound. 
    Via MarketBeat
    News headline image
    1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
    Via StockStory
    News headline image
    3 Reasons Investors Love DexCom (DXCM)
    DexCom trades at $74.63 per share and has stayed right on track with the overall market, gaining 8.3% over the last six months. At the same time, the S&P 500... 
    Via StockStory
    Topics Stocks
    News headline image
    1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm
    The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
    Via StockStory
    DexCom Inc (NASDAQ:DXCM) Passes Rigorous Quality Screen with Strong Profitability and Growth Metrics ↗
    Via Chartmill
    These S&P500 stocks have an unusual volume in today's session ↗
    Via Chartmill
    DexCom Inc (NASDAQ:DXCM): A GARP Stock with Affordable Growth and Strong Fundamentals ↗
    Via Chartmill
    News headline image
    Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
    From DexCom, Inc.
    Via Business Wire
    News headline image
    DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
    DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out? 
    Via The Motley Fool
    News headline image
    Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
    From Dexcom
    Via Business Wire
    News headline image
    2 Growth Stocks to Buy and Hold for a Decade ↗
    They have outpaced the S&P 500 over the past 10 years. 
    Via The Motley Fool
    Topics Artificial Intelligence Stocks
    News headline image
    Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
    From Dexcom
    Via Business Wire
    News headline image
    Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
    From DexCom, Inc.
    Via Business Wire
    Stay informed with the top movers within the S&P500 index on Tuesday. ↗
    Via Chartmill
    News headline image
    Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
    From DexCom, Inc.
    Via Business Wire
    News headline image
    DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day ↗
    DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose monitoring, international expansion and... 
    Via MarketBeat
    What's going on in today's session: S&P500 movers ↗
    Via Chartmill
    Uncover the latest developments among S&P500 stocks in today's session. ↗
    Via Chartmill
    News headline image
    Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
    From DexCom, Inc.
    Via Business Wire
    News headline image
    Sell in May and Go Away—Starting With These 3 Stocks ↗
    Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call. 
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    2 Mid-Cap Stocks with Impressive Fundamentals and 1 We Question
    Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
    Via StockStory
    News headline image
    3 Quality Compounders Worth Your Attention
    Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr... 
    Via StockStory
    News headline image
    5 Insightful Analyst Questions From DexCom’s Q1 Earnings Call
    DexCom’s first quarter saw revenue growth driven by new product launches and increased adoption, particularly among people with type 2 diabetes who are not o... 
    Via StockStory
    Topics Earnings Economy
    News headline image
    3 Reasons Analysts Love DexCom ↗
    Via MarketBeat
    News headline image
    Dexcom to Host Investor Day on May 14, 2026
    From DexCom, Inc.
    Via Business Wire
    Friday's session: gap up and gap down stock in the S&P500 index ↗
    Via Chartmill
    What's going on in today's pre-market session: S&P500 movers ↗
    Via Chartmill
    News headline image
    DXCM Q1 Deep Dive: U.S. Growth Moderates as Product Momentum and Coverage Expansion Drive Strategy
    Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 15% year on year to $1.19 bil... 
    Via StockStory
    News headline image
    2 Nasdaq 100 Stocks with Solid Fundamentals and 1 We Find Risky
    The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a win... 
    Via StockStory
    News headline image
    DexCom (DXCM) Q1 2026 Earnings Transcript ↗
    DexCom (DXCM) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    49 50 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.